Ignite Creation Date:
2024-05-06 @ 7:26 AM
Last Modification Date:
2024-10-26 @ 11:48 AM
Study NCT ID:
NCT02530476
Status:
COMPLETED
Last Update Posted:
2020-03-31
First Post:
2015-08-19
Brief Title:
Phase III Study of Selective Inhibitor of Nuclear Export SINE Selinexor KPT-330 Sorafenib in Acute Myeloid Leukemia
Sponsor:
Organization:
MD Anderson Cancer Center